| Piyush R Viradia, MD | |
|
6405 Day St, Riverside, CA 92507-0901 | |
| (951) 697-5453 | |
| (951) 653-3975 |
| Full Name | Piyush R Viradia |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 50 Years |
| Location | 6405 Day St, Riverside, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720061633 | NPI | - | NPPES |
| ZZZ92058Z | Other | GROUP SITE LOCATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A39926 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Medical Clinic Inc | 2961492327 | 149 |
News Archive
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in chemotherapy-induced heart disease.
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 8 days ago
| Entity Name | Riverside Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720183403 PECOS PAC ID: 2961492327 Enrollment ID: O20040517000880 |
News Archive
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in chemotherapy-induced heart disease.
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Piyush R Viradia, MD 3660 Arlington Ave, Riverside, CA 92506-3912 Ph: (951) 782-5110 | Piyush R Viradia, MD 6405 Day St, Riverside, CA 92507-0901 Ph: (951) 697-5453 |
News Archive
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in chemotherapy-induced heart disease.
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 8 days ago
Dr. Chad Leroy Clark, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3865 Jackson St, Riverside, CA 92503 Phone: 951-352-5666 Fax: 951-352-5445 | |
Dr. David Stuart Siegel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3425 Torrey St, Riverside, CA 92503 Phone: 561-685-6148 | |
Doug John Williamson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Kenneth Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-788-3537 Fax: 951-788-3173 | |
Dr. Ernest Woodhouse, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4440 Magnolia Ave., Riverside, CA 92501 Phone: 951-788-3200 | |
Dr. Michael Kang, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-684-3910 | |
Dr. Humberto Alirio Silva, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3865 Jackson St, Riverside, CA 92503 Phone: 951-352-5666 Fax: 951-352-5445 |